Skip to main content

Table 3 Univariable analysis of subjective evaluation of pre-operative PDAC imaging findings and therapy efficacy of S-1 in the primary cohort

From: Whole-tumour evaluation with MRI and radiomics features to predict the efficacy of S-1 for adjuvant chemotherapy in postoperative pancreatic cancer patients: a pilot study

 

Non-response group (n = 16)

Response group (n = 15)

p value

T1WI

  

1.000

 Iso-intensity

1 (6.3%)

1 (6.7%)

 

 Mild hypo-intensity

15 (93.8%)

14 (93.3%)

 

T2WI

  

1.000

 Iso-/mild hypo-intensity

7 (43.8%)

7 (46.7%)

 

 Mild hyper-intensity

9 (56.3%)

8 (53.3%)

 

Morphology

  

0.037

 Regular

9 (56.3%)

14 (93.3%)

 

 Irregular

7 (43.8%)

1 (6.7%)

 

Tumour margins on T2WI

  

0.394

 Well defined

2 (12.5%)

4 (26.7%)

 

 Ill defined

14 (87.5%)

11 (73.3%)

 

Tumour margins on T1WI

  

0.473

 Well defined

5 (31.3%)

7 (46.7%)

 

 Ill defined

11 (68.6%)

8 (53.3%)

 

Tumour margins after enhancement

  

0.073

 Well defined

6 (37.5%)

11 (73.3%)

 

 Ill defined

10 (62.5%)

4 (26.7%)

 

Peripheral delayed enhancement of tumour

  

0.135

 Invisible

13 (81.3%)

8 (53.3%)

 

 Visible

3 (18.8%)

7 (46.7%)

 

Central delayed enhancement of tumour

  

0.473

 Invisible

8 (50.0%)

5 (33.3%)

 

 Visible

8 (50.0%)

10 (66.7%)

 

Necrosis of tumour

  

0.172

 Absence

11 (68.8%)

14 (93.3%)

 

 Presence

5 (31.3%)

1 (6.7%)

 

Peripancreatic infiltration

  

0.012

 Invisible

4 (25.0%)

11 (73.3%)

 

 Visible

12 (75.0%)

4 (26.7%)

 

Peripancreatic blood vessel invasion

  

1.000

 Invisible

10 (62.5%)

10 (66.7%)

 

 Visible

6 (37.5%)

5 (33.3%)

 

Artery invasion

  

0.654

 Invisible

14 (87.5%)

12 (80.0%)

 

 Visible

2 (12.5%)

3 (20.0%)

 

Vein invasion

  

0.704

 Invisible

10 (62.5%)

11 (73.3%)

 

 Visible

6 (37.5%)

4 (26.7%)

 

Pancreatic duct dilatation

  

0.704

 Absence

6 (37.5%)

4 (26.7%)

 

 Presence

10 (62.5%)

11 (73.3%)

 

Atrophy of upstream pancreas

  

0.458

 Absence

9 (56.3%)

11 (73.3%)

 

 Presence

7 (43.8%)

4 (26.7%)

 

Retention cyst formation

  

 Absence

16 (100.0%)

15 (100.0%)

 

 Presence

0 (0.0%)

0 (0.0%)

 
  1. Bold means statistically significant (p values < 0.05)